| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |